Negative regulation of Bmi-1 by AMPK and implication in cancer progression
Open Access
- 23 December 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (5) , 6188-6200
Abstract
Negative regulation of Bmi-1 by AMPK and implication in cancer progressionKeywords
This publication has 37 references indexed in Scilit:
- Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancerLung Cancer, 2012
- Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancerMolecular Cancer, 2011
- Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma—do they have a role?Virchows Archiv, 2010
- MicroRNA 128a Increases Intracellular ROS Level by Targeting Bmi-1 and Inhibits Medulloblastoma Cancer Cell Growth by Promoting SenescencePLOS ONE, 2010
- AMPK As a Metabolic Tumor Suppressor: Control of Metabolism and Cell GrowthFuture Oncology, 2010
- Prognostic significance of grading in lung adenocarcinomaCancer, 2009
- MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian CancerCancer Research, 2009
- Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-RenewalCancer Research, 2008
- [Association of Bmi-1 mRNA expression with differentiation, metastasis and prognosis of gastric carcinoma].2007
- SIMPLE mutation analysis in dominant demyelinating Charcot‐Marie‐Tooth disease: three novel mutationsJournal of the Peripheral Nervous System, 2006